Tomokazu Matsuura

Title: Inventor Spotlight: Tomokazu Matsuura from Tokyo, JP

Introduction

Tomokazu Matsuura is a distinguished inventor based in Tokyo, Japan. With a total of three patents to his name, Matsuura has made significant contributions to the fields of biomedical research and diagnostics.

Latest Patents

Matsuura's recent innovations include the patent for an antibody against human Transforming Growth Factor-beta (TGF-β) Latency Associated Protein (LAP) degradate. This monoclonal antibody is designed to recognize an integrin binding site in the TGF-β LAP degradate, potentially paving the way for new therapeutic applications. Another notable patent focuses on a method for investigating liver damage types. This method uses the level of lithocholic acid (LCA) in biological samples to differentiate between various types of liver injury, whether hepatocellular injury, cholestasis, or a mixed type.

Career Highlights

Throughout his career, Tomokazu Matsuura has collaborated with well-known companies such as Kirin Beer Company and Daiichi Sankyo Company, Limited. His work in these organizations has allowed him to refine his expertise and contribute to impactful inventions that address critical health challenges.

Collaborations

Matsuura’s professional journey includes collaborations with notable colleagues like Seishi Nagamori and Satoshi Hasumura. Their collective knowledge and skills have played a vital role in the development of innovative solutions in the medical field.

Conclusion

Tomokazu Matsuura continues to be an influential figure in medical research through his innovative inventions and collaborations. His groundbreaking patents not only showcase his talent as an inventor but also highlight the potential for his work to make significant impacts on patient diagnostics and treatment methodologies.